NCT06378281 Testing a New Method to Improve Informed Consent in Prison Research
| NCT ID | NCT06378281 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stéphanie Baggio |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-05-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Understanding of informed consent is often limited in prison, due to unique challenges faced by detained people. This study will test a modified "teach-to-goal" informed consent process compared to standard procedures. Conducted within a larger study on psychiatric outcomes, it aims to enhance ethical practices for vulnerable populations.
Eligibility Criteria
Inclusion Criteria: * inclusion in the parent-RCT * age ≥ 18 years * good command of French * absence of acute psychiatric disorder * providing written informed consent for study participation in the parent-RCT Exclusion Criteria: \- none.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06378281 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 65 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06378281 currently recruiting?
Yes, NCT06378281 is actively recruiting participants. Contact the research team at stephanie.baggio@unil.ch for enrollment information.
Where is the NCT06378281 trial being conducted?
This trial is being conducted at Geneva, Switzerland, Geneva, Switzerland.
Who is sponsoring the NCT06378281 clinical trial?
NCT06378281 is sponsored by Stéphanie Baggio. The trial plans to enroll 100 participants.